Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 42 of 59, showing 10 Applications out of 581 total, starting on record 411, ending on 420

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

411.

ECCT/16/02/01   ASSESSING THE ACCURACY, USABILITY AND ACCEPTABILITY OF CHILDREN’S AUTOMATED RESPIRATORY MONITOR AT SELECTED CLINICS IN TURKANA COUNTY, KENYA ‘
            ASSESSING THE ACCURACY, USABILITY AND ACCEPTABILITY OF CHILDREN’S AUTOMATED RESPIRATORY MONITOR AT SELECTED CLINICS IN  TURKANA COUNTY, KENYA ‘         
Principal Investigator(s)
1. ISAIAH MWANGI
Site(s) in Kenya
1. lodwar hospital (Turkana county)
 
21-03-2016 View

412.

ECCT/15/12/01   A Randomized Controlled Trial of ASPIRIN in Nulliparous Pregnant Women(ASPIRIN STUDY)
        Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN): A Prospective randomized, placebo-controlled, double-blinded clinical trial in western Kenya.   
Principal Investigator(s)
1. Prof Fabian Esamai Omoding Esamai
Site(s) in Kenya
1. Amukura, Lukolis,Nasewa,Matayos,Khunyangu, Bumala B (Busia county)
2. Sirisia, Chwele, Bokoli (Bung\'oma county)
3. Makunga, Mumias (Kakamega county)
 
16-02-2016 View

413.

ECCT/15/06/04   A5316
        A5316           Evaluating Pharmacokinetic Interactions with Vaginal Ring Contraceptives and Antiretroviral Therapy   
Principal Investigator(s)
1. Dr. Esther Mumbi Makanga Makanga
2. Dr. Victor Akelo Akelo
3. Dr.Victor O. Mudhune Mudhune
4. Dr. Kevin P. Cain Cain
Site(s) in Kenya
KEMRI- CDC
 
17-07-2015 View

414.

ECCT/18/11/01   PrIMA
              PrEP Implementation for Mothers in Antenatal Care            
Principal Investigator(s)
1. Grace John-Stewart John-Stewart
2. Jared Baeten
Site(s) in Kenya
1. Homa Bay County - 10 sites (Homa Bay county)
2. Siaya County - 10 sites (Siaya county)
 
16-05-2019 View

415.

ECCT/25/02/03   NOZE20240219TB
    “Validation of a Digital Olfaction Based Breathalyzer Device for Non-Invasive Detection of Volatile Biomarkers in Patients with and without Tuberculosis: Case Control Study”.   
Principal Investigator(s)
1. Ibrahim Daud
Site(s) in Kenya
KEMRI/WRP CRC Kericho
 
15-05-2025 View

416.

ECCT/22/03/08   CVIA 092
    “ A Phase 3 Multicenter, Observer Blind, Randomized, Controlled Study to Evaluate Safety (Ages 6 Months to 45 Years) and Non-inferiority (Ages 9-12 Months) of Multi-dose and Single-dose Vial Formulations of EuTCV (Vi-CRM197 Typhoid Conjugate Vaccine) against Typbar TCV® and Lot-to-Lot Consistency of the Immune Response (Ages 9-12 Months) to Multi-dose Vial Formulation EuTCV in Healthy African Participants”.    
Principal Investigator(s)
1. Dr Lucy Koech Chepkurui Koech
Site(s) in Kenya
KEMRI/ KERICHO CRC
 
31-05-2022 View

417.

ECCT/15/01/02  
      Study title  An observational pilot study to characterize the immune response  induced by the commercial Varicella Zoster Virus vaccine  Zostavax® (Merck) in healthy adult females in Nairobi, Kenya.  Clinical Phase IV      
Principal Investigator(s)
1. Prof Walter Jaoko Jaoko
Site(s) in Kenya
KAVI-INSTITUTE OF CLINICAL RESEARCH (KAVI-ICR)
 
10-03-2015 View

418.

ECCT/22/02/02   The Women TAF-FTC Benchmark
    Safety and Pharmacokinetics of TAF-FTC Pre-exposure Prophylaxis in Kenyan Cisgender women   
Principal Investigator(s)
1. Dr. Nelly Rwamba Mugo
Site(s) in Kenya
KEMRI-CCR PHRD Thika
 
18-11-2022 View

419.

ECCT/19/11/04   Second line switch to Dolutegravir (2SD) study
    Switching Treatment-Experienced, Integrase Inhibitor-Naïve, Virally Suppressed HIV-1 Infected Adults from Ritonavir boosted Protease Inhibitors to Dolutegravir: An Open-Label Randomized Controlled Trial               
Principal Investigator(s)
1. Loice Achieng
Site(s) in Kenya
1. Kenyatta National Hospital (Nairobi City county)
2. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county)
3. Thika Level 5 Hospital (Kiambu county)
4. Kiambu Level 5 Hospital (Kiambu county)
 
23-12-2019 View

420.

ECCT/24/06/04   ALNASA
    A PHASE III OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY OF ASTEGOLIMAB IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE       
Principal Investigator(s)
1. Jacqueline Mirera
Site(s) in Kenya
1. Clinical Research Health Network (CREA-N) (Machakos county)
 
23-10-2024 View